Mastodon

Fitokapli Valeriana + Pustyrnik mercana (Drops) Instructions for Use

Marketing Authorization Holder

Mercana Service, LLC (Russia)

Manufactured By

Kurortmedservis, LLC (Russia)

Or Manufactured By

PLUTON-PHARM, JSC (Russia)

Dosage Form

Bottle OTC Icon Fitokapli Valeriana + Pustyrnik mercana Oral drops: 25 ml, 50 ml, or 100 ml bottle

Dosage Form, Packaging, and Product Composition

Oral drops 100 ml
Biologically active components, not less than
Flavonol glycosides (iridoids) 20 mg

Composition concentrated extract of herbal complex (motherwort herb, valerian roots), distilled glycerin, glutamic acid, citric acid, potassium sorbate, sodium benzoate, sweeteners, water.

25 ml – bottles with a dropper or mechanical dispenser.
50 ml – bottles with a dropper or mechanical dispenser.
100 ml – bottles with a dropper or mechanical dispenser.

Properties

Dietary supplement.

Motherwort herb has a sedative, hypotensive, negative chronotropic, and cardiotonic effect. The action is due to the properties of biologically active substances contained in the plant (including glycosides, alkaloids, flavonoids, saponins).

Valerian causes a moderately pronounced sedative effect. The action is due to the content of essential oil, most of which is the ester of borneol and isovaleric acid. Valepotriates and alkaloids – valerine and chotenine – also have sedative properties. Valerian facilitates the onset of natural sleep. The sedative effect develops slowly but is quite stable. Valerenic acid and valepotriates have a weak antispasmodic effect. In addition, the complex of biologically active substances of valerian officinalis has a choleretic effect, enhances the secretory activity of the gastrointestinal mucosa, slows the heart rate, and dilates the coronary vessels. The regulation of cardiac activity is mediated through neuroregulatory mechanisms and a direct influence on the automation and conduction system of the heart.

When motherwort herb and valerian are combined, the sedative effect and the effect on the cardiovascular system are enhanced.

Scope of Application

Neurotic and astheno-neurotic disorders accompanied by sleep disturbances; neurasthenia, neuroses, and vegetative-vascular dystonia. Vegetative neuroses in the preclimacteric period, accompanied by increased blood pressure, tachycardia, and cardialgia. Increased excitability and tachycardia in hyperthyroidism.

ICD codes

ICD-10 code Indication
E05 Thyrotoxicosis [hyperthyroidism]
F45.3 Somatoform dysfunction of the autonomic nervous system
F48.0 Neurasthenia
F48.9 Unspecified neurotic disorder
F51.2 Nonorganic disorders of the sleep-wake schedule
N95.1 Menopausal and other perimenopausal disorders
N95.3 States associated with artificial menopause
R00.0 Tachycardia, unspecified (including nodal (sinus) NOS)
R03.0 Elevated blood-pressure reading without diagnosis of hypertension
R07.2 Pain in the heart region
R45.1 Restlessness and agitation
ICD-11 code Indication
5A02.Z Thyrotoxicosis, unspecified
6A8Z Affective disorders, unspecified
6B6Z Dissociative disorders, unspecified
6C20.Z Bodily distress disorder, unspecified
7B2Z Sleep-wake cycle disorders, unspecified
GA30.00 Menopausal or climacteric states in women
GA30.3 States associated with artificial menopause
MB24.F Restlessness
MC80.0Z Elevated blood pressure without diagnosis of hypertension, unspecified
MC81.Z Abnormalities of heart rhythm, unspecified
MC86 Precordial pain

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally. The dose is determined individually, depending on the product used.

Side Effects

In some cases allergic reactions.

Contraindications

Hypersensitivity to the components of the product used.

Special Instructions

This is not a medicinal product.

Consult a doctor before using the product.

Do not exceed the recommended dose of the product used.

In children, use only dietary supplements intended for the corresponding age group.

Drug Interactions

When used concomitantly with drugs that have a depressant effect on the central nervous system, their effect may be enhanced.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS